Latest article
SCM Lifescience to in-license iPSCs-based diabetes drug from U.S. agency
SCM Lifescience has agreed to license a diabetes drug that uses pancreatic beta cells derived from induced pluripotent stem cells...
Welsh health enterprise AFLUENCR in multi-million greenback Kiwi acquisition
Welsh fitness company AFLUENCR, led by founder and CEO Gareth Manger, today announced a multi-million dollar (NZ) acquisition by New Zealand-based MacroActive, the transactional...